CASP3 and age-related macular degeneration: Previous studies has demonstrated that isorhamnetin protected retinal pigment epithelium cells from apoptosis by suppressing ROS production and caspase-3 activation, suggesting its therapeutic potential for AMD prevention (Wang J. et al., 2018).